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The retinal pigment epithelium (RPE) contains melano-
somes similar to those found in the skin melanocytes, which
undergo dramatic light-dependent movements in fish and
amphibians. In mammals, those movements are more sub-
tle and appear to be regulated by the Rab27a GTPase and
the unconventional myosin, Myosin VIIa (MyoVIIa). Here we
address the hypothesis that a recently identified Rab27a-
and MyoVIIa-interacting protein, Myrip, promotes the
formation of a functional tripartite complex. In heterolo-
gous cultured cells, all three proteins co-immunoprecipi-
tated following overexpression. Rab27a and Myrip
localize to the peripheral membrane of RPE melanosomes
as observed by immunofluorescence and immunoelectron
microscopy. Melanosome dynamics were studied using
live-cell imaging of mouse RPE primary cultures. Wild-type
RPE melanosomes exhibited either stationary or slow
movement interrupted by bursts of fast movement, with
a peripheral directionality trend. Nocodazole treatment led
to melanosome paralysis, suggesting that movement re-
quires microtubule motors. Significant and similar altera-
tions in melanosome dynamics were observed when any
one of the three components of the complex was missing,
as studied in ashen- (Rab27a defective) and shaker-1 (Myo-
VIIa mutant)-derived RPE cells, and in wild-type RPE cells
transduced with adenovirus carrying specific sequences to
knockdown Myrip expression. We observed a significant
increase in the number of motile melanosomes, exhibiting
more frequent and prolonged bursts of fast movement, and
inversionofdirectionality.Similaralterationswere observed
upon cytochalasin D treatment, suggesting that the Ra-
b27a–Myrip–MyoVIIa complex regulates tethering of mela-
nosomes onto actin filaments, a process that ensures
melanosome movement towards the cell periphery.
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The retinal pigment epithelium (RPE) is part of the blood/
retina barrier and is composed of a pigmented monolayer
of polarized cells performing multiple functions. These
include absorption of light and protection against photo-
oxidation, transepithelial transport of nutrients, spatial
buffering of ions in the subretinal space, cycling of retinal,
phagocytosis and secretion of a variety of growth factors
(1,2). The apical membrane forms long processes that face
and partially envelop the photoreceptor outer segments.
This close interaction between RPE and photoreceptors is
essential for visual function. The RPE phagocytoses the
tips of shed photoreceptor outer segments and is neces-
sary for recycling of retinal used by photoreceptor opsins.
On its basolateral side, the RPE faces Bruch’s membrane
and the fenestrated endothelium of the choriocapillaris.
Melanin pigment is contained within the cytoplasm in
melanosomes of skin and choroidal melanocytes, and RPE
(1). Pigment must play animportant roleinthe development
of the neural retina because albino mice, lacking the key
melanogenicenzymetyrosinase,presentabnormalpatterns
of cell proliferation and reduced numbers of photoreceptors
(3). In adults, melanosomes may be important in absorption
of stray light and free radicals. Contrary to fish and amphib-
ians where melanosomes of the RPE redistribute dramat-
ically from the cell body into the apical processes upon
onset of light in a reversible manner, mammalian melano-
somes undergo only a modest light and/or circadian cycle-
dependent redistribution into the apical processes (1,4), and
exhibit motility in isolated primary RPE cultures (1,5).
The process of melanosome motility has been extensively
studied in melanocytes of the skin. Once mature, melano-
somes are first transported to the peripheral region of the
cell by long-range, bidirectional, microtubule (MT)-depen-
dent movements and are then transferred to actin fila-
ments and carried by short-range, local movements (6,7).
Re-use of this article is permitted in accordance with the
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mechanism (8), after which they are translocated from the
melanocyte dendrites to adjacent epidermal keratinocytes
(9). Translocation from MT-based to actin-based transport
requires a tripartite complex, composed of Rab27a, Mela-
nophilin (Mlph) and Myosin Va (MyoVa). Rab27a attached
to the melanosome membrane binds Mlph, a linker protein
that in turn binds to MyoVa, the actin-based motor (10–12).
Loss of any of the partners of the complex leads to
clustering of the melanosomes in the perinuclear region,
as shown in studies involving melanocytes from ashen
(lacking functional Rab27a) (13), leaden (mutant for Mlph)
(14,15) and dilute (absence of MyoVa) (8), resulting in coat
colour dilution in mice and partial albinism in humans.
The movement along MTs has been extensively studied in
melanophores, where pigment aggregation and dispersion
can be easily manipulated by addition of melatonin and
melanocyte-stimulating hormone, respectively, revealing
the role of MTs and their associated motors, dynein and
kinesin, in pigment distribution (16). The mechanism by
which two motors of opposite polarity act to control the
bidirectional movement of melanosomes on MTs originally
described by a tug-of-war model (17) was more recently
suggested to occur via a MT-motor co-ordination model
(18). On the other hand, co-ordination between actin- and
MT-based movement appears to be regulated by a tug-
of-war mechanism, where both motors are present in the
same cargo molecule at the same time (19), and impair-
ment of one component, such as actin in MyoVa-deficient
cells, increases the contribution of the other (8,17,20).
These studies proposed that MyoVa acts by terminating
a minus-end run and moving the melanosome away from
the MT network, its action being regulated by the number
of MyoVa molecules associated with cargo (17).
Contrary to what is known for melanophores and mela-
nocytes, the contribution of each cytoskeletal filament sys-
tem in melanosome transport is not well understood in
RPE cells. Studies in cultures of dissociated fish RPE cells,
which undergo dramatic pigment granule movement as
observed in melanophores (16), using the MT-dissociating
agent nocodazole suggested that MTs had no effect on
aggregation or dispersion of pigment, while the actin-
depolymerizing agent cytochalasin D inhibited both disper-
sion and aggregation, as well as impaired the maintenance
of the fully aggregated and dispersed states (21). In mam-
mals, the molecular mechanisms involved in melanosome
movement in the RPE are much less well characterized, but
recent evidence points to a conserved mechanism with skin
melanocytes (11). Rab27a appears to recruit another uncon-
ventional myosin, Myosin VIIa (MyoVIIa), for the movement
of melanosomes into the apical processes of the RPE. In
ashen and shaker-1 (lacking functional MyoVIIa) mice
mutant strains, the distribution of RPE melanosomes is
altered, with melanosomes found exclusively in the cell
body of the RPE, failing to move beyond the level of the
adherens junctions (4,5,22). The RPE in leaden mice
appears normal, indicating that Mlph does not act as the
linker protein between Rab27a and MyoVIIa in RPE cells
(4,5). A likely candidate for a Rab27a and MyoVIIa linker
protein is Myrip [also called synaptotagmin-like protein
lacking C2 domains (Slac2-c)]. Myrip is a 96-kDa protein,
which was originally identified as a MyoVIIa tail-binding
protein (23,24). Myrip contains a typical Rab27a-binding
motif, is able to bind to MyoVIIa and Rab27a and is ex-
pressed in the RPE where it associates with melanosomes
(23). However, the direct involvement of Myrip in melano-
some motility in the RPE remains to be demonstrated. This
issue represents the focus of the present study.
Results
Formation of a tripartite complex between Rab27a,
Myrip and MyoVIIa in the RPE
In order to establish a system to address the hypothesis that
Myrip serves as a functional linker between Rab27a and
MyoVIIa in RPE, we developed a mouse RPE primary cell
culture based on Wollmann et al. (25,26). The RPE cultures
were essentially clear of any other retinal cell type, and RPE
primary cells maintained their characteristic physiological
features, such as cuboidal shape and pigmentation (Figure 1
A). Immunoblot of primary cell extracts showed the expres-
sion of the RPE-specific marker RPE65 and Rab27a at
comparable levels to skin melanocytes (Figure 1B). We
generated a specific antibody against Myrip and detected
endogenous Myrip in RPE primary cultures but not in skin
melanocytes (Figure 1B). We did not assay for MyoVIIa due
to lack of a suitable antibody but its expression in RPE cells
has been reported previously (5). We also attempted to de-
tect expression of the melanocyte-specific isoform of MyoVa
in the RPE cultures, but the results were negative despite
loading twice the amount of protein compared to controls
(wild-type melanocytes and HEK-293 cells) (Figure 1B).
In order to test whether Rab27a, Myrip and MyoVIIa could
potentially form a complex, we used a heterologous
expression system and performed co-immunoprecipitation
studies (Figure 1C). COS-7 cells were co-transfected with
green fluorescent protein (GFP)-Myrip, untagged Rab27a
and V5-MyoVIIa tail [corresponding to amino acids (aa)
1671-stop]. Total extracts were assayed for the presence
of the overexpressed proteins, and then incubated with
anti-V5 antibody. V5-MyoVIIa tail immunoprecipitates also
contained Rab27a and Myrip. Both full-length and a Myrip
fragment containing aa 1–414 were able to associate with
both Rab27a and MyoVIIa (Figure 1C). In the absence of
Rab27a input or when using a deletion Myrip (195–414)
construct, MyoVIIa tail was still able to pull-down Myrip, as
expected from the proposed model where Myrip serves as
a linker protein between Rab27a and MyoVIIa. Conversely,
a fragment of Myrip encoding aa 407–652 was unable to
co-immunoprecipitate with MyoVIIa tail. Therefore, the
fragment 1–414 of Myrip appears necessary and sufficient
to establish the link between MyoVIIa and Rab27a.
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the formation of the complex under more physiological
conditions. RPE primary cultures were transduced with
adenoviruses (Ad) encoding full-length MyoVIIa fused
with GFP. After 2 days, total cell extracts were incubated
with anti-GFP antibody and anti-GFP immunoprecipitates
were shown to contain Myrip (detected with anti-Myrip
antibody) and Rab27a (detected with 4B12 antibody)
(unpublished observations). Thus, the heterologous co-
immunoprecipitation experiments suggest that a tripartite
complex can indeed form, as previously suggested (27).
We then analysed the localization of Myrip and Rab27a in
primary cultures of the RPE from adult mice by immuno-
fluorescence microscopy. Rab27a and Myrip were found
predominantly on mature melanosomes, regardless of
shape or location. Merged images of endogenous Myrip
with false-coloured melanosomes revealed the presence
of concentric rings surrounding melanosomes (Figure 2
C,D,G,H). The similar pattern of staining suggests that
Rab27a and Myrip co-localize in the outer melanosome
membrane. It is noteworthy to mention that other non-
pigmented structures are also specifically stained with
both antibodies, especially in the case of Rab27a (Figure
2I). It is likely that Rab27a and its effectors associate
with other cellular organelles, such as secretory granules.
Conversely, approximately 20–25% of melanosomes did
not exhibit staining (Figure 2J). Melanin is known to
quench fluorescence, which may account for some mela-
nized structures without apparent staining.
To confirm the IF studies, we performed immunoelectron
microscopy. This high-resolution technique demonstrated
that the majority of melanosomes are heavily labelled for
Myrip (Figure 2K) and confirmed the co-localization of
Myrip and Rab27a on the melanosomal membrane where
they were frequently present in clusters (Figure 2L).
Functional requirement of the Rab27a–Myrip–MyoVIIa
complex for RPE melanosome motility
The absence of an animal model where Myrip loss-
of-function could be studied prompted us to attempt a
Figure 1: Formation of a Rab27a–Myrip–MyoVIIa tripartite
complex. A) Phase contrast image of cultured primary wild-type
RPE cells at low magnification (  40); Bar ¼ 20 mm. B) Protein
extracts prepared from wild-type murine RPE primary cells, ashen
melanocytes, melan-ink (wild type) melanocytes and HEK-293
were separated by SDS–PAGE and immunoblotted for Rab27a,
Myrip, RPE65, MyoVa and calnexin (as a loading control) as
described under Materials and Methods. C) Plasmids encoding
V5-MyoVIIa tail, GFP-Myrip and Rab27a were co-transfected into
COS-7 cells and the expressed proteins were immunoprecipitated
with anti-V5 or anti-Rab27a antibody as described under Materials
and Methods. The bottom panels show total lysates after trans-
fection, indicating transfection efficiencies. Top panels show immu-
noprecipitated proteins revealed by the indicated antibodies.
[Correction added after publication 3 April 2007: the label in bottom
part of Figure 1B was corrected from a-MyoVIIa to a-MyoVa]
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Melanosome Movement in the RPEshort-hairpinRNA(shRNA) approachincultured RPE primary
cells. We designed specific oligonucleotide sequences
and tested for their ability to reduce the levels of over-
expressed epitope-tagged mouse Myrip in HEK-293 cells
(Figure 3A). Out of nine sequences tested, three (shRNA5,
7 and 8) led to a significant decrease in the level of
expressed V5-Myrip and were selected for subsequent
studies. One of the non-effective shRNA (shRNA4) was
also selected to be used as a negative control. The
sequences were used to construct adenoviruses express-
ing these specific shRNAs and the recombinant viruses
were used to transduce RPE primary cultures. To confirm
the knockdown (KD) of endogenous Myrip in RPE cells,
transduced cells were analysed by immunofluorescence
(Figure 3B). We confirmed that no apparent Myrip labell-
ing could be detected in cells expressing GFP-shRNA5
(Figure 3B, panel E), -7 and -8 (unpublished observations),
as opposed to non-transducing (Figure 3B, panel B) and
cells expressing shRNA4 (Figure 3B, panel H). There was
no apparent phenotype in any of the mutant or transducing
cells, such as changes in cell shape, pigment level or
distribution of melanosomes (Figure 3). These observa-
tions contrast with the striking clustering of melanosomes
in skin melanocytes upon Rab27a/Mlph/MyoVa depletion.
We then studied melanosome dynamics in live RPE-
cultured cells using time-lapse microscopy. We analysed
ashen (Rab27a mutant), shaker-1 (MyoVIIa mutant) and
anti-Myrip shRNA-treated wild-type RPE cells. In order to
assess the specificity of the effects, we also performed
rescue experiments by reintroducing the missing proteins
(in the case of Myrip, an shRNA resistant clone from
a different species) using recombinant adenoviruses.
Movies depicting melanosome dynamics were obtained
for 175 seconds, capturing a frame every 0.5 seconds (see
Supplementary Movies) and were analysed using manual-
tracking software.
Quantitative analysis of the trajectories of random selected
melanosomes revealed significant differences between
RPE cultures. Wild-type cells exhibited many motile mela-
nosomes (60.4%, Table 1), undergoing usually short and
directional trajectories. In an attempt to determine the
cytoskeletal tracts involved, we treated cells with nocoda-
zole (a MT-disrupting agent) and cytochalasin D (which
caps actin filaments inducing reorganization of the actin
filamentsinshortactinpatches).Theefficiencyofthetreat-
ment was determined by immunofluorescence staining
with anti-tubulin and phalloidin, respectively (Figure 4). In
nocodazole-treated cells,melanosomes appeared stationary
(Tables 1 and 2), while in cytochalasin D-treated cells
melanosomes exhibited dynamics similar to those
observed in ashen, shaker-1 and Myrip shRNA-treated
cells, although generally less pronounced (Tables 1 and 2
and see below). These results implicate both MT- and
actin-based motors in the observed melanosome motility.
RPE mutant cells for any of the proposed components of
the tripartite complex exhibited more motile melano-
somes, which underwent rapid bidirectional movement,
including a number of reversal steps (Figure 4; Table 1).
Quantitative analysis of our data revealed a 40–60%
increase in number of motile melanosomes (typically
above 80%) in the absence of Rab27a, Myrip or MyoVIIa,
compared to baseline numbers of 50–60% for wild-type
cells (Table 1). Cytochalasin D treatment resulted in moti-
lity rates between wild type and mutants (Table 1). Con-
sistently, nocodazole-treated cells exhibited less than 20%
motile melanosomes (Table 1). The number of reversal
steps was also quantified. All three mutant and cytochalasin
D-treated cells exhibited a twofold increase in reversal
steps when compared to controls (Table 1). The reversal
steps are probably the result of the movement along MTs,
driven by kinesin and dynein in reverse directions.
It has been previously shown that shaker-1 RPE primary
cultures exhibit an increased average linear displacement
profile (5). As confirmed in this study, RPE control cells
exhibited several melanosome motility speeds, either
stationary or slow movements (typically  250 nm/second)
interrupted by bursts of faster movement (>1000 nm/
second) (Figure 4 and Supplementary Movies). Con-
versely, in mutant RPE cells the bursts of movement were
more prolonged and frequent, resulting in a longer average
linear displacement (Figure 4; Table 2). When Rab27a or
Myrip were deficient, the average linear displacement
increased approximately threefold when compared with
control values (approximately 30 mm versus 10 mm)
(Table 2). In shaker-1 RPE cells, the increase was less
pronounced (approximately 20 mm versus 10 mm). Kymo-
graph profiles of live-cell imaging data show differences in
velocity undergone by melanosomes from different
mutant backgrounds. In controls, any movement is pre-
ceded andfollowed by analmost absenceof movement. In
mutant cells, the distance moved in one single step is
larger, and melanosomes do not tend to remain stationary
following movement (Figure 5). To demonstrate the spe-
cificity of the effects, we performed rescue experiments
by reintroducing the missing proteins. When transducing
adenovirus-encoding GFP-Rab27a, ashen cells return to
Figure 2: Subcellular localization of Rab27a and Myrip in RPE. Wild-type murine RPE cells were fixed, permeabilized and labelled with
antibodies to Myrip (A) or Rab27a (E), as indicated. B and F) These panels show the corresponding phase contrast images and (C) and (G)
are merged fluorescent and phase contrast images. D and H) These panels show boxed regions at higher magnification. Bar ¼ 4 mm.
Quantification of melanized and non-melanized structures staining with anti-Rab27a (I) and anti-Myrip (J) are represented. K and L) These
panels show immunoelectron microscopy sections of wild-type murine RPE from retinal sections labelled with anti-Myrip antibody and
15 nm protein A–gold (G) or anti-Myrip antibody (10 nm gold) and anti-Rab27a (15 nm gold indicated by arrows) (H). AJ, adherens junction.
Bar ¼ 200 nm.
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above for other parameters. A similar effect was observed
with shaker-1 cells, when GFP-MyoVIIa was introduced
(Table 2). As for Myrip, control cells were KD with the
relevant shRNA and simultaneously transduced an adeno-
virus-encoding rat Myrip, a cDNA resistant to the shRNA
effect (unpublished observations). Reintroduction of Myrip
restored wild-type melanosome dynamics as shown by all
the quantitative methods used (Figure 5; Tables 1 and 2).
Also in agreement with the other quantitative analysis,
Figure 3: Efficiency of shRNAs to KD Myrip expression. A) HEK-293FT cells were co-transfected with pENTR/CMV-V5-Myrip and
pENTR/U6-shRNA. Protein extracts were subjected to immunoblot using anti-V5 antibody. B) Wild-type RPE cells were fixed,
permeabilized and subjected to immunofluorescence using anti-Myrip antibody. Wild-type RPE cells expressing no GFP-shRNA
(panels A–C), GFP-Myrip shRNA5 (panels D–F) and GFP non-specific shRNA4 (panels G–H) were labelled with Myrip antibody, as
indicated. Bar ¼ 20 mm.
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nosome paralysis, while cytochalasin D induced increased
average linear displacement comparable to shaker-1 cells
and lower than ashen and Myrip shRNA-treated cells
(Figure 5; Table 2).
A possible role for MyoVa has been previously proposed,
given its reported association with RPE melanosomes (5).
Despite our inability to detect MyoVa in RPE cultures by
immunoblot, we analysed melanosome dynamics in Myo-
Va-deficient RPE primary cultures derived from dilute-lethal
mice.Ouranalysisrevealedmotilitycharacteristicssimilarto
wild-type cells (Figure 4; Tables 1 and 2, see also Supple-
mentary Movie 8). Furthermore, we observed that the
alterations in melanosome dynamics in Myrip KD RPE cells
were not rescued by transduction of Mlph, a Myrip-related
protein and the critical linker of Rab27a and MyoVa in skin
melanocytes. These results are consistent with normal
melanosome distribution in RPE in vivo in dilute mice (4,5).
Finally, we studied whether there is directionality of
melanosome motility in cultured RPE cells. Melanosomes
were followed for 30 seconds and the melanosome
position relative to the nucleus was calculated for each
frame. Our results suggest that melanosomes undergo
a directed non-diffusive motion, as expected (unpublished
observations). In wild-type and ashen-rescued cells, the
majority of melanosomes exhibited predominantly motion
towards the periphery of the cell (Figure 6A). This centri-
fugal directionality was disrupted in the Rab27a, Myrip and
to a lesser extent MyoVIIa mutant cells and cytochalasin D-
treated RPE cells. We also calculated the relative ratio of
centrifugal (towards the periphery) and centripetal
(towards the nucleus) steps (Figure 6B,C). The histogram
in Figure 6B reflects the average velocity obtained for the
ratio of anterograde/retrograde steps. Due to a smaller
number of reversal steps, control cells have a higher
velocity ratio towards the periphery. In the mutant cells
analysed, the results suggest lower values and even re-
versal in directionality in Rab27a- and Myrip-deficient cells
(Figure 6B). In the graph depicted in Figure 6C, values >1
demonstrate a centrifugal tendency and <1 a centripetal
tendency. The data confirmed that wild-type (and rescued)
cells showed a peripheral directionality trend, reflected in
the higher number of centrifugal steps while ashen and
Myrip KD cells exhibited a trend towards reverse direc-
tionality (Figure 6). Cytochalasin D-treated and shaker-1
cells also showed increased number of pauses and rever-
sals but no clear tendency (Figure 6). The milder pheno-
type observed in shaker-1 and cytochalasin D-treated RPE
cells was consistently observed across the different
experiments and analysis methods.
Discussion
The results presented here demonstrate a functional role
for the Rab27a–Myrip–MyoVIIa complex in melanosome
motility in RPE. We show that the knockout or KD of any of
the three proteins elicit the same melanosome dynamics
phenotype in primary RPE cultures. Our results confirm
previous suggestions that Rab27a is able to associate with
different unconventional myosins (such as MyoVa and
MyoVIIa) through a pair of related proteins, Mlph and
Myrip (11). The evidence presented here also suggests
that the Rab27a–Myrip–MyoVIIa complex is involved in
anchoring melanosomes to the actin cytoskeleton, which
in turn result in directional movement of melanosomes
towards the periphery of the cell.
The Rab27a GTPase serves as a maturation sensor that is
recruited onto mature secretory granules and lysosome-
related organelles (28). Once activated, Rab27a-GTP can
potentially interact with at least 11 effector proteins (also
called Exophilins). Among these, Myrip (or Slac2-c) and
Mlph (or Slac2-a) form a unique family of Rab27- and
Myosin-interacting proteins. They can be structurally
divided into several domains. At the N-terminus, they
contain two sequence homology domains (SHD), SHD1
and SHD2, representing the Rab27-binding domain (29). In
the medial region of protein, Mlph contains a complex
myosin-bindingregion, which includesa high-affinitysitefor
a melanocyte-specific isoform of MyoVa (30–32) and a con-
served coiled-coil region (33), while the myosin-binding
region of Myrip remains less well characterized. Previous
studies showed that deletion of the Rab27-binding domain
(aa 1–146) did not affect the binding to MyoVIIa (23,24),
a finding confirmed in this study. A previous study
suggested that the region containing aa 409–602 (24)
was necessary for binding to MyoVIIa, a finding not
supported by our biochemical data presented in Figure 1.
Instead, our data suggest that the myosin-binding region
in Myrip maps to aa 195–414. Interestingly, this MyoVIIa-
binding region is not conserved between Myrip and Mlph,
a finding consistent with the inability of Mlph to bind
MyoVIIa (24). We caution however that the interaction
Table 1: Analysis of motile melanosome population and fraction
of reversal steps. Fraction of reversal steps was calculated in a
30-second interval.
RPE source Percentage
of motile
melanosomes
Average number
of reversal steps
Wild type 60.4   4.3 0.9
Shaker-1 86.2   3.5 1.7
Ashen 87.3   5.2 2.06
Ashen þ Ad GFP-Rab27a 56.4   4.1 1
Wild type þ Ad
GFP-shRNA5 mMyrip
94.1   2.15 2.13
Wild type treated
with nocodazole
18.4   5.4 0
Wild type treated
with cytochalasin D
72.2   3.6 2.2
Dilute 54.7   1.9 1.1
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we have recently observed for Mlph–MyoVa interaction
(33). Thus, more detailed studies will be necessary to
unravel the molecular basis for these interactions.
MyoVIIa has been previously implicated in melanosome
motility in RPE (5,22). Our immunofluorescence and
immunoelectron microscopy studies confirmed the RPE
melanosomal membrane localization of Rab27a (4) and
Myrip (23). Interestingly, we often observed that Myrip-
associated gold particles were found in small clusters,
suggesting the presence of membrane microdomains, as
suggested for Rab27a in secretory granules (34), and Rabs
4, 5, 11 in endosomes (35). The presence of other vesicular
structures stained by Myrip and particularly Rab27a raises
the possibility that these proteins may serve other roles in
membrane-trafficking pathways in RPE cells. Consistently,
MyoVIIa has been implicated in lysosomal movement (36)
and phagocytosis (37) in the RPE. Additionally, Rab8 was
also implicated in actin-dependent movement of melano-
somes in skin melanocytes (38) but the relevance of these
observations to RPE cells remains unclear.
In intact retinas, the absence of MyoVIIa or Rab27a leads
to redistribution of melanosomes from the F-actin-rich
apical region and processes to the MT-rich cell body
(4,5). The time-lapse microscopy studies and motility
analysis described here are broadly consistent with results
recently described for the MyoVIIa-deficient RPE cells
derived from shaker-1 mice (5). Furthermore, the new data
extend these previous studies in several significant ways.
First, we demonstrate that nocodazole treatment lead to
an almost complete loss of melanosome movement in
mammalian RPE cells. Previous studies in isolated fish
RPE cells suggested that MTs and MT-motors were not
important for melanosome movements (21). Our studies
suggest instead that, at least in mammals, melanosome
movements are executed primarily by kinesins and dyne-
ins. Fast-moving melanosomes travel in one direction,
pause and often reverse direction (Figures 4; Table 1;
Supplementary Movies), as described in melanophores
(17,39). Second, our studies clearly implicate Myrip as the
Figure 4: Live-cell imaging of RPE primary cultures and distribution of MTs and actin filaments. Phase contrast images of primary
RPE cells at high magnification (  100) are shown. Zoomedimages showing representative trajectoriesdrawn during the entire time frame
collected during live-cell imaging illustrates the movement of melanosomes in representative wild-type RPE cell (A), shaker-1 RPE cell (B),
ashenRPEcell(C),ashenRPEcelltransduced withAdGFP-Rab27a (D),wild-typeRPEcelltransduced withAdshRNA5Myrip(E), wild-type
RPE cell treated with nocodazole (F) or cytochalasin D (G) and dilute RPE cell (H). Regions used for the movies are marked for each case.
Wild-type murine RPE cells were fixed, permeabilized and labelled with phalloidin (I) or anti-tubulin (K), as indicated. Cells treated with
10 mM cytochalasin D were also stained with phalloidin (J), while cells incubated with 10 mM nocodazole were labelled with anti-tubulin (L).
Bar ¼ 20 mm.
Table 2: Mean linear displacement resulting from movements as
described under Materials and Methods in the indicated RPE
cultures (mean   standard deviation).
RPE source Melanosome average
displacement (mm)
Wild type 9.2   0.4
Wild type þ Ad GFP 10.5   0.7
Shaker-1 23.1   1.5
Shaker-1 þ Ad GFP-MyoVIIa 10.8   2.3
Ashen 31.8   1.4
Ashen þ Ad GFP-Rab27a 10.5   0.6
Wild type þ Ad GFP-shRNA5 mMyrip 28.0   1.4
Wild-type þ Ad GFP-shRNA7 mMyrip 34.5   2.1
Wild type þ Ad GFP-shRNA8 mMyrip 30.5   1.8
Wild type þ Ad GFP-shRNA4 mMyrip 10.1   0.7
Wild type þ Ad GFP-shRNA5 mMyrip
þ Ad GFP-rMyrip
9.79   0.8
Wild type treated with nocodazole 2.94   0.9
Wild type treated with cytochalasin D 21.4   1.5
Dilute 14.4   0.8
Wild type þ Ad GFP-shRNA5 mMyrip
þ Ad GFP-mMlph
27.05   2.99
Figure 5: Analysis of melanosome dynamics in RPE primary
cultures. Representative kymograph tracings illustrating move-
ment of individual melanosomes are shown for the indicated RPE
cultures. Arrows indicate bursts of rapid movement. Tracing was
started around 10–15 seconds before rapid movement was
noticed.
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Lopes et al.functional linker bridging Rab27a and MyoVIIa because the
loss of any one of the three proteins examined resulted in
similar phenotypes. We demonstrate that the loss of the
Rab27a–Myrip–MyoVIIa complex leads to a significant
(50%) increase in the number of motile melanosomes,
a greater fluctuation in their orientation and a wider aver-
age displacement. Third, our results suggest that melano-
somes do move preferentially towards the periphery of
the cell in wild-type RPE cells. Furthermore, loss of
the Rab27a–Myrip–MyoVIIa complex activity leads to a
reversal (or neutrality) in this directionality. This is broadly
consistent with extensive observations in skin melano-
cytes upon loss of Rab27a, Mlph or MyoVa (11). Fourth,
melanosome motility in RPE-cultured cells is also affected
Figure 6: Melanosome motion direc-
tionality. Histograms representing the
fraction of melanosomes with centrifugal
movement (A) and average melanosome
anterograde/retrogradevelocity(mm/second)
(B) are shown for the indicated RPE
cultures (mean   standard deviation). C)
Frequency of the ratio of number centrifu-
gal/centripetal steps performed in a popu-
lation of 25 melanosomes during a 30-
second period.
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Melanosome Movement in the RPEby cytochalasin D treatment (Figures 4–6; Tables 1 and 2),
whose cells exhibited melanosome dynamics similar to
those observed in ashen, shaker-1 and Myrip KD cells. The
similarities between cytochalasin D treatment and dis-
ruption of any component of the Rab27a–Myrip–MyoVIIa
complex suggest that the complex is involved in the
tethering of melanosomes with the actin cytoskeleton.
We suggest that loss-of-function of the RPE Rab27a–
Myrip–MyoVIIa complex leads to a reduced constraint on
MT-based motility, as revealed by the melanosome
dynamics alterations described above. Our data imply that
this protein complex is involved in the switch from MT- to
actin-based motility as proposed in skin melanocytes for
the Rab27a–Mlph–MyoVa complex. We also suggest that
these data provide further evidence for a tug-of-war
mechanism operating between actin and MT transport
systems in mammalian RPE cells, as suggested in frog
melanophores (17). When the association with actin is
disrupted, MT-based movement takes over, and direction-
ality is lost. The association with actin, possibly by disrupt-
ing MT minus-end runs of melanosomes, may be
responsible for the directionality of movement towards
the periphery, which in vivo would result in movement into
the apical processes, where actin is localized (4). Interest-
ingly, the severity of the phenotypes observed varied,
appearing more severe in ashen and Myrip KD as com-
pared to shaker-1 cells. These findings raise the possibility
of some functional compensation, namely other possible
connections of Rab27a–Myrip with other myosin motor
proteins. It is noteworthy that our investigations into
a possible role of MyoVa in this process have so far yield
only negative data. Furthermore, cytochalasin D-treated
cells also showed a milder, intermediate phenotype. The
simplest explanation in our view is that the cytochalasin D
effect under the conditions used did not completely disrupt
all Rab27a–Myrip–MyoVIIa complex activity.
Altogether,ourresultsareconsistentwithamodelwhereby
MT-based motility is hindered by myosin-driven actin
tethering of melanosomes. Nevertheless, the importance
of melanosome movements in retinal physiology remains
an open question. Mislocalization of melanosomes is not
a probable cause for the photoreceptor degeneration
found in patients suffering from Usher 1B syndrome
caused by MyoVIIa mutations, as this process may be
triggered by photoreceptor-specific functions of MyoVIIa
and/or a role in RPE phagocytosis leading to a delay in
degradation of phagosomes (37). Further work will be
needed to clarify these issues.
In summary, mammalian cells seem to have developed
a transport unit composed of a small GTPase, linker protein
and motor protein enabling dissociation from MT-based
motors and connection with the actin cytoskeleton. Using
a single membrane marker, the system may use different
combinations by varying a small number of linkers and
motors.
Materials and Methods
Animals and cell lines
All mice, including ashen (C57BL/6J; ash/ash) (40), dilute-lethal (DLS/LeJ)
and homozygous agouti shaker-1 (C57BL/6J; Myo7a
4626SB/4626SB) (4) col-
onies were bred and maintained on 12-h light/dark cycle under UK project
license PPL 70/6210 at the Central Biomedical Services of Imperial College
London. C57BL/6 wild-type mice were purchased from B&K Universal Ltd
(Hull, UK).
Retinal pigmented epithelium primary cultures
RPE primary cultures were isolated according to a modified protocol from
Wollmann et al. (25,26). Eyes from 3-week-old mice were enucleated,
incubated with PBS without Mg
2þ/Ca
2þ for 20 min, transferred to warm
buffer [PBS plus 1 mM ethylenediaminetetraacetic acid (EDTA)] for 20 min
at 378C, the neuroretina was gently peeled off, and the remaining eyecup
was treated with 1 U of preactivated papain (Sigma, Sigma-Aldrich,
Gillingham, UK) in dissociation buffer (PBS plus 1 mM EDTA, 26 nM
L-cysteine, 1 mg/mL BSA) for 35 min. Papain was activated by incubating 1 U
in dissociation buffer for 30 min. Patches of RPE were manually removed
with pulses of growth media. Cells were then transferred to media, in order
to inactivate the enzyme, centrifuged gently for 5 min at 100   g,a n d
grown in DMEM high glucose supplemented with 15% FBS, 1  MEM non-
essential aa, 100 U/mL penicillin, 100 mg/mL streptomycin, 2.5 mg/mL
gentamycin and 50 ng/mL amphothericin B at 378C and 10% CO2,f o r
adequate periods of time. Cell cultures reagents were purchased from
Gibco unless specified. For experiments involving nocodazole and cytocha-
lasin D, cells were treated with 10 mM of the drug for 1 h at 378C.
Antibodies
The C-terminal region (aa 644–780) of rat Myrip was fused to glutathione
S-transferase as described below and the recombinant protein was pro-
duced in Escherichia coli and purified on glutathione–Sepharose beads, as
described previously (31). Anti-Myrip antibodies were produced in rabbits
by Davids Biotechnologie (Regensburg, Germany), affinity purified from
sera using the same antigen immobilized on AminoLink Coupling Gel
(Pierce, Rockford, IL) as described previously (14,41) and used at 1:20
dilution for immunofluorescence studies, 1:20 for immunoelectron micros-
copy and 1:250 for immunoblotting. Anti-Rab27a monoclonal 4B12 and
polyclonal Q142 antibodies were described previously (14). Anti-MyoVa
antibody was raised against exons D and F of mouse MyoVa, affinity
purified as described above and used for immunoblot at 1:500. Other
antibodies were used as follows: monoclonal anti-RPE65 (Abcam, Cam-
bridge, UK, IF (immunofluorescence): 1:20, IB (immunoblot): 1:250) and
polyclonal anti-calnexin (Stressgen, Victoria, Canada, IB: 1:10 000).
Vectors and recombinant viruses
Mouse Myrip cDNA was amplified from pFLCI mMyrip (GenBank acession
number AK083225, Fantom clone C630029J04) by polymerase chain
reaction (PCR) using Phusion polymerase (New England Biolabs, Hitchin,
UK). The PCR fragment was inserted into the pcDNA3.1/V5/His TOPO
vector (Invitrogen, Paisley, UK) as instructed by the manufacturer. Full-
length Myrip was removed from pcDNA3.1/V5/His using HindIII/SalIa n d
inserted into pENTR-GFPC2 using the same restriction sites. Mouse Mlph
was excised from pEGFPC2 (33) using EcoRI/KpnI and ligated into pENTR-
GFPC2 using the same restriction sites. pENTR-GFPC2 and pENTR-GFPC3
were constructed on a backbone of pENTR286 (33), an expression
mammalian vector with Gateway
 technology (Invitrogen), by swapping
part of the promoter and the polylinker with the equivalent sequences
containing GFP-coding sequence from pEGFPC2 or pEGFPC3 (Clontech,
Mountain View, CA) using NdeI/BamHI restriction sites. Rat Myrip was
cloned by reverse transcriptase (RT)–PCR using total RNA isolated from rat
retina with RNeasy kit (Qiagen, Crawley, UK). RT–PCR was performed
according to the manufacturers’ instructions using SuperScript II (Invitro-
gen). The rMyrip-coding sequence was digested with EcoRI/SalI and cloned
into pENTR-GFPC2 and pENTR-V5C2 using the same restriction sites.
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part of the promoter and the polylinker with the equivalent sequences
containing V5 tag sequence from pCMV-V5 previously generated using
NdeI/BamHI restriction sites. pCMV-V5 expression mammalian vector was
constructed on a backbone of pEGFPC1 (Clontech) by changing GFP for V5
sequence using the NheI/BglII restriction sites. In order to generate anti-
Myrip antibody, the rMyrip sequence corresponding to aa 644–780 was
amplified using pENTR-V5C2 rMyrip as a template. After digestion with
EcoRI and SalI, the cDNA fragment was cloned into pGEX4T-1 (Amersham,
Bucks, UK) using the same restriction sites. Human MyoVIIa head domain
(1–632) was cloned by RT–PCR using total RNA isolated from human retina
(Eye Bank at Coimbra University Hospital) as described above. Human
MyoVIIa tail was subcloned from two EST clones (GenBank acession
number BE780659, IMAGE 3872258; GenBank accession number
BI835786, IMAGE 5226439). In order to clone full-length hMyoVIIa-coding
sequence into the mammalian expression vector pENTR286 with Gateway
technology (33), a BsiWI and a SpeI restriction sites were inserted by PCR.
The order of the cloning was as follows: MyoVIIa tail (aa 1111 stop) using
SpeI/NotI, MyoVIIa tail (aa 633–1110) using BsiWI/SpeI and MyoVIIa head
(aa 1–632) using EcoRI/BsiWI. In order to tag MyoVIIa with GFP at the
N-terminus, GFP was removed from pcDNA3.1/V5/His GFP using EcoRI/
EcoRI and inserted into pENTR286 MyoVIIa full length using the EcoRI
restriction site. pcDNA3.1/V5/His GFP was previous generated by amplifi-
cation of GFP with pEGFPC1 (Clontech) as a template and cloned into
pcDNA3.1/V5/His TOPO (Invitrogen) according to the manufacturers’
instructions. In order to generate Ad GFP-Rab27a, the mammalian expres-
sion cassette (CMV promoter/GFP/rRab27a/polyA) was amplified from
pEGFP-rRab27a using Phusion, cut with SalI/BamHI and cloned into
pENTR286 (33) using the same restriction sites. Short-hairpin RNA (shRNA)
-expressing vectors were constructed by inserting an inverted repeat of
Myrip-specific 21-nucleotide sequences into pENTR/U6 plasmid harbouring
PolIII U6 promoter obtained from Invitrogen. For shRNA targeting of mouse
Myrip, the oligonucleotides were annealed and ligated into pENTR/U6
according to manufacturers’ instructions (underline indicates RNA inter-
ference target sequences). The following oligonucleotides were used:
shRNA mMyrip 5 sense: CACCGCAGAGAGACTTCAATCTTCGCGAAC-
GAAGATTGAAGTCTCTCTGC, antisense: AAAAGCAGAGAGACTT-
CAATCTTCGTTCGCGAAGATTGAAGTCTCTCTGC; shRNA mMyrip 7
sense: CACCGGAGGATTGTTTGAACCAAACTTCAAGAGAGTTTGGTT-
CAAACAATCCTCC, antisense: AAAAGGAGGATTGTTTGAACCAAACT-
CTCTTGAAGTTTGGTTCAAACAATCCTCC; shRNA mMyrip 8 sense:
CACCGCTGAGAAATAGACTGTATGATTCAAGAGATCATACAGTCTATT-
TCTCAGC, antisense: AAAAGCTGAGAAATAGACTGTATGATCTCTTGAAT-
CATACAGTCTATTTCTCAGC and shRNA mMyrip 4 sense:
CACCGGACTTGATGGAGCCTGATCTTTCAAGAGAAGATCAGGCTCCATCA-
AGTCC. All plasmids were verified by DNA sequencing. Myrip shRNA or
cDNA encoding the proteins of interest were cloned according to manu-
facturers’ instructions into pAd adenoviral vector from Invitrogen using
Gateway technology.
Cell culture
Melan-ink4a melanocytes were maintained in RPMI-1640 supplemented
with 10% FCS, 200 nM phorbol 12-myristate 13-acetate and 200 pM cholera
toxin at 378C with 10% CO2, as described previously (33). 293FT human
embryo kidney cells obtained from Invitrogen were grown in DMEM in the
presence of 10% FBS and antibiotics at 378C and 10% CO2. Cells were
co-transfected in six-well plates with pENTR/U6-Myrip shRNA and pENTR-
V5-mMyrip using Lipofectamine (Invitrogen) as instructed by the manufac-
turer. At 24 h post-transfection cells were lysed in plates by using lysis
buffer [50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1% CHAPS {3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate}, 1 mM phenylme-
thylsulphonyl fluoride (PMSF), 1 mM DTT and complete protease inhibitor
cocktail (Roche, West Sussex, UK)]. Proteins were separated by SDS–
PAGE and visualized by immunoblotting using PVDF (polyvinylidene di-
fluoride) membranes and anti-V5 antibody (Invitrogen) (1:2000). In order to
produce adenoviral particles, 293A cells obtained from Invitrogen were
grown in DMEM containing 10% FBS, 1  non-essential aa, 100 U/mL
penicillin and 100 mg/mL streptomycin at 378C and 10% CO2. Cells were
transfected in 60-mm culture dishes with pAd DNA previously digested
with PacI using Lipofectamine 2000 (Invitrogen) as instructed by the
manufacturer. Medium containing adenovirus particles was collected when
approximately 80% cytopathic effect is observed (typically 10–13 days
post-transfection) and centrifuged as described by Invitrogen. Adenovirus
expressing shRNA under the control of the PolIII promoter and the GFP
gene under the control of CMV promoter or GFP-Rab27a, GFP-rMyrip, GFP-
hMyoVIIa genes also under the control of the cytomegalovirus promoter
were used in the range 1   10
7–1   10
8 particles per millilitre to transduce
RPE primary cultures from ashen, shaker-1 and wild-type mice.
Immunoprecipitation
Cells grown in 60-mm culture dishes were lysed for 30 min in lysis buffer
[50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1% CHAPS, 1 mM PMSF, 1 mM
DTT and complete protease inhibitor cocktail (Roche)]. Lysates were
clarified by microcentrifugation for 15 min at 13000   g at 48C. For V5
immunoprecipitations, lysates diluted 2 times with the same buffer without
detergents were incubated with 2 mg of V5 antibody overnight at 48C with
rotation, and immune complexes were captured also overnight at 48Co f
incubation with 50 mL of protein G–Sepharose beads (Amersham). Immune
complexes were washed with lysis buffer and incubated in SDS gel-loading
buffer for 3 min at 958C. Proteins were separated by SDS–PAGE and
visualized by immunoblotting as above. The same basic protocol was used
with RPE cells, with the exception that immunoprecipitation was per-
formed with 2 mg of GFP antibody (Abcam) and complexes were captured
with protein A–Sepharose beads (Amersham).
Immunofluorescence and confocal microscopy
Cells used for immunofluorescence were grown on glass coverslips, and
transducing adenovirus where indicated. Cells were washed with PBS,
fixed with 4% (w/v) paraformaldehyde (PFA) in PBS for 15 min, rinsed twice
with PBS, incubated for 10 min with 50 mM NH4Cl in PBS and permeabilized
with 0.05% saponin/0.5% BSA in PBS for 45 min. Permeabilized cells were
incubated with theprimary antibodies for 1h at room temperature,followed
by four washes and incubation with Alexa 568-conjugated and Alexa 488-
conjugated secondary antibodies (Molecular Probes, Paisley, UK, 1:200) for
another hour at room temperature. All incubations and washing steps were
carried out in 0.05% saponin/0.5% BSA in PBS. The coverslips were
mounted in ImmunoFluor medium (ICN, Basingstone, Hants, UK) and
visualized using a Leica DM-IRBE confocal microscope (Leica, Wetzlar,
Germany). Images were processed using TCS-NT software (Leica) and ADOBE
PHOTOSHOP 5.5 software. All images shown are single sections in the z-plane
and representative of at least 80% of transducing cells.
Time-lapse analysis of melanosome dynamics and
quantitative analysis
Living cells were visualized in a time-lapse bright field microscope (Zeiss
Axiovert, UK), using a   100 oil objective. The temperature of the chamber
was maintained at 378C, using a hot air source. Groups of 350 images were
acquired at 500-millisecond intervals, totalizing 175 seconds, with a CCD
camera (Hamamatsu Orca, ER, Shizuoka-Ken, Japan). Image acquisition
was performed using OPENLAB 5.0 software. Image stacks obtained were
then imported into IMAGEJ software (National Institutes of Health, Bethesda,
MA, USA) and linear displacement in two dimensions and average velocity
were measured using the Manual-Tracking plugin (http://rsb.info.nih.gov/ij/
plugins). A total of 100 motile melanosomes were sampled randomly from
three independent cultures of primary RPE cells for each mutant and
controls. Kymographs were generated using the Multiple Kymograph plugin
(http://rsb.info.nih.gov/ij/plugins). The percentage of motile melanosomes
was done by randomly tracking melanosomes and considering as immotile
melanosomes those moving less than 1 mm during the time frame analysed
(175 seconds) (n > 400 for each case). The total number of reversals steps
was calculated in 25 moving melanosomes during a period of 30 seconds,
and defined as a movement in the opposite direction the melanosome
followed previously. Directionality analysis was performed for some of the
cultured RPE cells. Melanosomes were followed during 30 seconds and
Traffic 2007; 8: 486–499 497
Melanosome Movement in the RPEtheir x and y co-ordinates recorded. Position of the melanosome relative to
the nucleus was calculated for each frame. A positive value was considered
centrifugal movement and a negative value as centripetal movement.
Electron microscopy
Mouseeyes were fixed in 4% PFA, 0.1% glutaraldehyde in 0.1 M phosphate
buffer and embedded as previously described (4). Sections (70 nm) were
cut at  1208C, picked up in 1:1 sucrose:methylcellulose and immunogold
labelled as described (4). For labelling with rabbit primary antibodies, swine
anti-rabbit IgG intermediate antibody was used before protein A–gold to
enhance the signal. For Myrip and Rab27a double labelling, sections were
first labelled with anti-Myrip, intermediate antibody and 10 nm protein
A–gold, were then fixed in 1% glutaraldehyde for 15 min and finally were
labelled with anti-Rab27a, intermediate antibody and 15 nm protein A–gold.
Sections were viewed under a Joel 1010 electron microscope.
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Supplementary Material
Time-lapse movies showing melanosome dynamics in RPE primary
cultured cells. Images were captured every 0.5 seconds, and the movies
show one in each two frames, at a frame rate of 7 fps. Movie 1: wild-type
RPE cell; Movie 2: shaker-1 RPE cell; Movie 3: ashen RPE cell; Movie 4:
ashen RPE cell transduced with Ad GFP-Rab27a; Movie 5: Wild-type RPE
cell transduced with Ad shRNA5 Myrip; Movie 6: wild-type RPE cell treated
with nocodazole; Movie 7: wild-type RPE cell treated with cytochalasin D;
Movie 8: dilute RPE cell.
Supplemental materials are available as part of the online article at http://
www.blackwell-synergy.com
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